Carrie B. Nelson

Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinoxaline-2,3-dione and related quinoxalinediones: characterization of .alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity

Christopher F. Bigge, Thomas C. Malone, Peter A. Boxer et al. · Journal of Medicinal Chemistry · 1995 · 58 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Design and Synthesis of Novel Quinoxaline-2,3-dione AMPA/Gly_N Receptor Antagonists:  Amino Acid Derivatives

Sham S. Nikam, John J. Cordon, Daniel F. Ortwine et al. · Journal of Medicinal Chemistry · 1999 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification and characterization of m4 selective muscarinic antagonists

Corinne E. Augelli‐Szafran, Juan C. Jaén, D.W. Moreland et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 38 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Design and Synthesis of m1-Selective Muscarinic Agonists:  (<i>R</i>)-(−)-(<i>Z</i>)-1-Azabicyclo[2.2.1]heptan-3-one, <i>O</i>-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI<b>-</b>1017), a Functionally m1-Selective Muscarinic Agonist

Haile Tecle, Stephen D. Barrett, David Lauffer et al. · Journal of Medicinal Chemistry · 1998 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology

Haile Tecle, Roy D. Schwarz, Stephen D. Barrett et al. · Pharmaceutica Acta Helvetiae · 2000 · 13 citations

Medicine, Medicinal Chemistry, Pharmacology +11